Current financial disclosure for ______________ for years _______

Financial Disclosure
For:
Paul W. Armstrong, University Professor, University of Alberta, Edmonton, Alberta ** Updated:

Monetary amounts are on an annual basis

Company/(Companies):
Period of
Name of Project
1) A research
2) A research 3) Educational
4) Consulting or
5) I receive
Comments
activities or
other services for
significant
equity in
contract from contract
lectures for this
this company
personal
this Company from this
generates
royalties
partially
generates revenue
personal income
from this
supports my
partially
for the University
University
supports my
of Alberta
research
projects
<$10K
>$10K
<$10K
>$10K
Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)” STABILITY Protocol LPL100601 Company/(Companies):
Period of
Name of Project
1) A research
2) A research 3) Educational
4) Consulting or
5) I receive
Comments
activities or
other services for
significant
equity in
contract from contract
lectures for this
this company
personal
this Company from this
generates
royalties
partially
generates revenue
personal income
from this
supports my
partially
for the University
University
supports my
of Alberta
research
projects
<$10K
>$10K
<$10K
>$10K
Evaluate Cardiovascular Outcomes after Treatment with Sitagliptin in Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control on Mono- or Dual Combination Oral Antihyperglycemic Therapy (TECOS) Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome (ODYSSEY Outcomes) Company/(Companies):
Period of
Name of Project
1) A research
2) A research 3) Educational
4) Consulting or
5) I receive
Comments
activities or
other services for
significant
equity in
contract from contract
lectures for this
this company
personal
this Company from this
generates
royalties
partially
generates revenue
personal income
from this
supports my
partially
for the University
University
supports my
of Alberta
research
projects
<$10K
>$10K
<$10K
>$10K

** Please note this document should be placed in the context that Dr. Armstrong is working 0.5 FTE at the University.
In accordance with the American Heart Association conflict of interest policies.
Column Explanations:

(1) Funding is provided for my effort in research grants/ contracts for multi-center projects in which I serve in an executive function, this often is combined with Canadian operational responsibility.
Remuneration for such work is received through Capital Health in Edmonton. A portion of my University income, administered through the Department of Medicine, is supported by these funds. (2) A research grant from this company supports the expenses associated with projects in the Canadian VIGOUR Centre or University of Alberta that are under my direction. (3) I provide educational activities or deliver occasional lectures that generate revenue from this company. All revenues from these activities are paid to the Capital Health. None of it is taken for personal income. The two columns represent annual payments of more or less than $10,000 per year from this company. (4) I receive personal income outside of my University salary for consulting or other services (possibly including CME) from this company. The three columns represent annual payments of more or (5) I personally receive no royalties from any industrial firm. (6) Neither me nor any member of my family have equity in any industrial firm.

Source: http://vigour.ualberta.ca/en/About/~/media/vigour/Publication%20Resources/Financial%20Disclosure%20Form%20PWA%20December2013.pdf